Hutchmed (China) LTD (HMDCF) — SEC Filings

Q: What are the key financial highlights for Hutchmed (China) LTD?

Key financial highlights for Hutchmed (China) LTD are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: What is the investment thesis for HMDCF?

The investment thesis for HMDCF includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings filed by Hutchmed (China) LTD.

Q: Who are the key executives at Hutchmed (China) LTD?

Key executives at Hutchmed (China) LTD are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Hutchmed (China) LTD stock?

Risk factors for Hutchmed (China) LTD (HMDCF) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Hutchmed (China) LTD?

Forward-looking statements and predictions from Hutchmed (China) LTD are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Hutchmed (China) LTD. Recent 6-K filing on Dec 31, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Hutchmed (China) LTD on SEC EDGAR

Overview

Hutchmed (China) LTD (HMDCF) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Dec 31, 2025: HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 31, 2025. This report is for the month of December 2025 and indicates the company files annual reports under Form 20-F. The company's principal executive offices are located in Hong Kong.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant filing sentiment for Hutchmed (China) LTD is neutral.

Filing Type Overview

Hutchmed (China) LTD (HMDCF) has filed 49 6-K, 1 20-F with the SEC between Dec 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

HUTCHMED (China) Ltd Files 6-K for December 2025 — 6-K · Dec 31, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 31, 2025. This report is for the month of December 2025 and indica
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Dec 30, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 30, 2025. This report is for the month of December 2025 and indica
6-K Filing — 6-K · Dec 29, 2025
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Dec 17, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 17, 2025. This report is for the month of December 2025 and indica
6-K Filing — 6-K · Dec 8, 2025
6-K Filing — 6-K · Nov 28, 2025
6-K Filing — 6-K · Nov 5, 2025
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Nov 3, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on November 3, 2025. This report is for the month of November 2025 and indicat
HUTCHMED (China) Ltd Files 6-K — 6-K · Oct 23, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on October 23, 2025, reporting its status as a foreign private issuer. The company, formerly known as Hutchison China
HUTCHMED (China) Ltd Files October 2025 6-K Report — 6-K · Oct 21, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on October 21, 2025. This report is for the month of October 2025 and indicate
HUTCHMED (China) Ltd Files October 2025 6-K Report — 6-K · Oct 14, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on October 14, 2025. This report is for the month of October 2025 and indicate
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Oct 2, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on October 2, 2025. This report is for the month of October 2025 and indicates
HUTCHMED (China) Ltd Files 6-K for September 2025 — 6-K · Sep 30, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on September 30, 2025. This report is for the month of September 2025 and indi
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Sep 12, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on September 12, 2025. This report is for the month of September 2025 and indi
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Sep 5, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on September 5, 2025, reporting its status as a foreign private issuer. The company, formerly known as Hutchison China
HUTCHMED (China) Ltd Files August 2025 6-K Report — 6-K · Aug 25, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on August 25, 2025, reporting its activities for the month of August 2025. The company, formerly known as Hutchison Ch
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Aug 20, 2025 Risk: low
HUTCHMED (China) Ltd filed a Form 6-K on August 20, 2025, reporting as a foreign private issuer. The company, formerly known as Hutchison China MediTech Ltd, is
HUTCHMED (China) Ltd Files 6-K with Financial Updates — 6-K · Aug 7, 2025 Risk: low
HUTCHMED (China) Ltd filed a 6-K report on August 7, 2025, for the period ending June 30, 2025. The filing includes financial information and details on subsequ
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Jul 3, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on July 3, 2025, reporting as a foreign private issuer. The filing indicates the company previously operated under the
HUTCHMED (China) Ltd Files July 2025 6-K Report — 6-K · Jul 2, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on July 2, 2025, reporting for the month of July 2025. The company, formerly known as Hutchison China MediTech Ltd, is
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Jun 30, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on June 30, 2025, reporting for the month of June 2025. The company, previously known as Hutchison China MediTech Ltd,
HUTCHMED (China) Ltd Files June 2025 6-K Report — 6-K · Jun 10, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on June 10, 2025. This report is for the month of June 2025 and indicates the
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Jun 5, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on June 5, 2025, reporting as a foreign private issuer. The filing indicates the company previously operated under the
HUTCHMED (China) Ltd Files June 2025 6-K Report — 6-K · Jun 2, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on June 2, 2025. This report is for the month of June 2025 and is filed as a r
HUTCHMED (China) Ltd Files Routine 6-K Disclosure — 6-K · May 30, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on May 30, 2025, reporting its status as a foreign private issuer. The filing does not contain specific financial upda
HUTCHMED (China) Ltd Files 6-K, Name Change Noted — 6-K · May 23, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on May 23, 2025, reporting its status as a foreign private issuer. The filing indicates the company previously operate
HUTCHMED (China) Ltd Files Routine 6-K Disclosure — 6-K · May 13, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on May 13, 2025, reporting as a foreign private issuer. The filing does not contain specific financial figures or oper
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Apr 24, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on April 24, 2025, reporting as a foreign private issuer. The filing does not contain specific financial details or op
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Apr 22, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on April 22, 2025. This report is for the month of April 2025 and indicates that the company files annual reports unde
HUTCHMED Files 2024 Annual Report & AGM Notices — 6-K · Apr 7, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on April 7, 2025, to report its 2024 Annual Report (Exhibit 99.1) and related announcements. These include a notice of
HUTCHMED (China) Ltd Files March 2025 6-K Report — 6-K · Mar 31, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 31, 2025, reporting for the month of March 2025. The filing indicates the company is a foreign private issuer
HUTCHMED (China) Ltd Files March 2025 6-K Report — 6-K · Mar 21, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 21, 2025. This report is for the month of March 2025 and indicates the company files annual reports under For
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Mar 20, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 20, 2025. This report is for the month of March 2025 and indicates the company files annual reports under For
HUTCHMED (China) Ltd Files 2024 Year-End Results — 6-K · Mar 19, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 19, 2025, to report its final results for the year ended December 31, 2024. The filing includes an announceme
HUTCHMED (China) Ltd Files Routine 6-K Disclosure — 6-K · Mar 19, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 19, 2025, reporting as a foreign private issuer. The filing does not contain specific financial figures or op
HUTCHMED (China) Ltd Files 2024 Annual Report — 20-F · Mar 19, 2025 Risk: medium
HUTCHMED (China) Ltd filed its 20-F for the fiscal year ending December 31, 2024. The company, previously known as Hutchison China MediTech Ltd, is a pharmaceut
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Mar 14, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 14, 2025. This report is for the month of March 2025 and indicates that the company files annual reports unde
HUTCHMED (China) Ltd Announces Extraordinary General Meeting — 6-K · Mar 13, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 13, 2025, to announce an extraordinary general meeting. The filing includes an announcement and notice relate
HUTCHMED (China) Ltd Files March 2025 6-K Report — 6-K · Mar 6, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 6, 2025. This report is for the month of March 2025 and indicates the company files annual reports under Form
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Mar 5, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 5, 2025, reporting as a foreign private issuer. The filing does not contain specific financial details or ope
HUTCHMED (China) Ltd Files March 2025 6-K Report — 6-K · Mar 3, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on March 3, 2025, reporting its activities for the month of March 2025. The filing is a report of a foreign private is
HUTCHMED (China) Ltd Files February 2025 6-K Report — 6-K · Feb 28, 2025 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on February 28, 2025. This report is for the month of February 2025 and indica
HUTCHMED (China) Ltd Files Routine 6-K Report — 6-K · Feb 19, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on February 19, 2025. This report is for the month of February 2025 and indicates that the company files annual report
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Jan 28, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on January 28, 2025, reporting as a foreign private issuer. The filing indicates the company previously operated under
HUTCHMED (China) Ltd Files January 2025 6-K Report — 6-K · Jan 14, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on January 14, 2025. This report is for the month of January 2025 and indicates that the company files annual reports
HUTCHMED (China) Ltd Files Routine 6-K — 6-K · Jan 2, 2025 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on January 2, 2025, reporting as a foreign private issuer. The filing does not contain specific financial figures or o
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Dec 31, 2024 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 31, 2024. This report is for the month of December 2024 and indica
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Dec 30, 2024 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 30, 2024. This report is for the month of December 2024 and indica
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Dec 13, 2024 Risk: low
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 13, 2024. This report is for the month of December 2024 and is fil
HUTCHMED (China) Ltd Files 6-K Report — 6-K · Dec 12, 2024 Risk: low
HUTCHMED (China) Limited filed a Form 6-K on December 12, 2024. This filing is a report of a foreign private issuer and does not contain specific financial deta

Risk Profile

Risk Assessment: Of HMDCF's 46 recent filings, 0 were flagged as high-risk, 1 as medium-risk, and 45 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Top Tags

foreign-private-issuer (30) · sec-filing (17) · reporting (13) · regulatory-filing (10) · disclosure (8) · corporate-update (5) · filing (4) · 6-K (4) · routine-filing (3) · compliance (3)

Key Numbers

Reporting Period End Date: 2025-06-30 — Indicates the end date for the financial data presented.
Prior Year End Date: 2024-12-31 — Provides a comparative balance sheet date.
SEC File Number: 001-37710 — Identifies the specific filing with the SEC
Fiscal Year End: 20241231 — The reporting period covered by the 20-F filing.

Frequently Asked Questions

What are the latest SEC filings for Hutchmed (China) LTD (HMDCF)?

Hutchmed (China) LTD has 50 recent SEC filings from Dec 2024 to Dec 2025, including 49 6-K, 1 20-F. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of HMDCF filings?

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant sentiment is neutral.

Where can I find Hutchmed (China) LTD SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Hutchmed (China) LTD (HMDCF) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Hutchmed (China) LTD?

Financial highlights for Hutchmed (China) LTD are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for HMDCF?

Investment thesis data for HMDCF will be available once enriched filings are processed.

Who are the key executives at Hutchmed (China) LTD?

Executive information for Hutchmed (China) LTD is extracted from SEC filings as they are enriched with AI analysis.

What are the main risk factors for Hutchmed (China) LTD stock?

Of HMDCF's 46 assessed filings, 0 were flagged high-risk, 1 medium-risk, and 45 low-risk.

What are recent predictions and forward guidance from Hutchmed (China) LTD?

Forward guidance and predictions for Hutchmed (China) LTD are extracted from SEC filings as they are enriched.